Document is current
Any future updates will be listed below
-
Authors
Walter, Lauren D. https://orcid.org/0000-0001-7445-8207
Orton, Jessica L.
Ntekas, Ioannis https://orcid.org/0000-0002-4157-1665
Fong, Ern Hwei Hannah
Maymi, Viviana I. https://orcid.org/0000-0002-1575-3510
Rudd, Brian D. https://orcid.org/0000-0002-9742-8358
De Vlaminck, Iwijn https://orcid.org/0000-0001-6085-7311
Elisseeff, Jennifer H. https://orcid.org/0000-0002-5066-1996
Cosgrove, Benjamin D. https://orcid.org/0000-0003-2164-350X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01AG058630, R01AR081449, U54AG07977, T32HD057854, F30OD032097, U54AG07977, DP1AR076959, R01AG058630, R01AR081449)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (R01AI105265)
- License Information
-
More Information
Article History
Received: 9 June 2023
Accepted: 18 October 2024
First Online: 22 November 2024
Competing interests
: J.H.E. was previously a consultant and holds equity in Unity Biotechnology and Aegeria Soft Tissue and is an advisor for Tessera Therapeutics, HapInScience, Regenity and Font Bio. The other authors declare no competing interests.
